The function of Cthrc1 as a stimulator of bone formation without affecting bone resorption is very promising, because most types of drugs which are currently used for the treatment of osteoporosis are antiresorptive in nature and insufficient for restoring bone volume in osteoporotic patients [23]. This evidence concerns the gene CTHRC1 and osteoporosis.